<?xml version="1.0" encoding="UTF-8"?>
<ref id="JVEv5-bib-0047">
 <label>47.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Crowell</surname>
    <given-names>TA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Colby</surname>
    <given-names>DJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pinyakorn</surname>
    <given-names>S</given-names>
   </name>
   <etal>et al.</etal>
  </person-group>
  <article-title>Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial</article-title>. 
  <source>Lancet HIV</source>
  <year>2019</year>; 
  <volume>6</volume>
  <bold>(</bold>
  <issue>5</issue>
  <bold>)</bold>: 
  <fpage>e297</fpage>â€“ 
  <lpage>e306</lpage>.
  <pub-id pub-id-type="pmid">31000477</pub-id>
 </mixed-citation>
</ref>
